AGP Executive Report

Food Safety: FSSAI has questioned health claims on infant formulas and children’s products from Nestlé, Zydus Wellness and Abbott, including Complan’s “2X growth” claim, and sought scientific support. Air Quality: Delhi’s AQI crossed 200 after Dussehra, prompting Stage 1 GRAP curbs as pollution worsens. Medical Training: Jammu and Kashmir has more than doubled MBBS and BDS interns’ monthly stipend to ₹25,000, effective October 1; interns have called off their strike. Cancer Care: India will cut prices of 137 cancer medicines by up to 70% from November 9, a major potential relief for patients facing high treatment costs.

Air Quality: Delhi-NCR’s AQI reached 244 on October 21, prompting Stage 1 GRAP curbs, including restrictions on open burning and coal-fired tandoors. Cancer Care: Prices of 137 cancer medicines are set to fall by up to 70% from November 9. An Indian AI-based breast cancer test may also help identify early-stage patients who could avoid chemotherapy. Affordable Treatment: Ayushman Bharat is helping low-income families in Jharkhand’s Koderma access cashless care; three Delhi MCD hospitals will offer CT and MRI scans at rates 20% below CGHS prices. Advanced Therapies: Bharat Biotech subsidiary Nucelion and VeGen Bio will work on manufacturing a CAR-T therapy for multiple myeloma in India, with the aim of reducing costs and widening access. Mental Health: Police are investigating the death of a 19-year-old Mumbai college student; reports say he had been receiving treatment for depression.

Affordable Diagnostics: MCD hospitals in Delhi will offer CT scans and MRI tests at rates 20% below CGHS prices at three facilities, with a ₹120-crore private investment planned over 10 years. Medical Education: Ladakh’s first medical college is approved to begin operations in 2027–28, expanding local training and healthcare capacity. Cancer Care: Prices of 137 anti-cancer medicines are set to fall from November 9, with some reports citing reductions of up to 70%. Food Safety: FSSAI has issued notices to Nestlé India and Hindustan Unilever over nutrition claims and labelling, amid wider checks on food sellers and products. Public Health: Delhi plans a ₹104-crore pollution-control pilot across 40 locations as air quality worsens; the government also plans to use 85 testing platforms for hepatitis B and C. Rare Diseases: Patients are urging the government to arrange interim treatment funding, while doctors in Bhubaneswar highlighted alkaptonuria, a rare inherited disease, in a new medical report.

Food Safety: FSSAI has warned supplement makers to add required cautions to products containing herbal extracts, with licence suspension and penalties possible for violations. Delhi inspectors also found pest and hygiene lapses at festive sweet-making units and collected samples for testing. Clean Air: Delhi’s winter plan includes a “No PUC, No Fuel” rule, restrictions on non-BS-VI vehicles from outside the capital and construction curbs from November 1. Medical Workforce: Jammu and Kashmir medical interns have resumed their strike, saying the government missed its promised deadline to raise stipends. Healthcare Access: Ladakh’s first medical college in Leh is expected to open in 2027-28 after approval to recruit staff before construction is 80% complete. Bone Health: On World Osteoporosis Day, doctors urge assessment after fractures from minor falls, alongside treatment, nutrition and rehabilitation to prevent another injury. Cancer Care: India is set to cut prices of 137 anti-cancer medicines from November 9, offering patients potential relief.

Hospital Oversight: Mumbai’s civic corporation is awaiting an inquiry report into the death of a 13-year-old at HBT Trauma Hospital; her father alleges doctors failed to admit her despite a dengue test result. Healthcare Investment: Bengaluru-based Even Healthcare raised $50 million and plans to open five hospitals in the city over the next six months. Food Safety: FSSAI has warned nutraceutical and supplement firms to meet labelling rules, while notices over nutrition claims have also gone to Nestlé India and Hindustan Unilever. Cancer Care: Prices of 137 cancer medicines are set to fall from November 9, with reductions of up to 70%. Infant Nutrition: FSSAI has proposed banning added sugars in nutrition products for babies up to six months. Mental Health: Goa’s free Tele-MANAS counselling service has received more than 40,000 calls since its 2023 launch.

Hospital Expansion: Bengaluru-based Even Healthcare raised $50 million from Khosla Ventures and plans to open five hospitals in the city over the next six months. Cancer Care: The government has capped trade margins on 137 anti-cancer medicines, with revised prices expected to fall by up to 70% from November 9. Rare Diseases: Patient groups have urged the government to restore treatment funding for people who have exhausted the ₹50 lakh limit under the National Policy for Rare Diseases; 164 patients are affected. Women’s Health: Delhi High Court permitted a 16-year-old rape survivor to terminate a 31-week pregnancy, saying a minor should not be expected to bear the burden of childbirth. Medical Education: The NMC withdrew its 2023 standards regulations but said medical colleges must continue submitting annual disclosure reports.

Mass-Casualty Incidents: Kolkata’s Durga Puja stampede has killed 19 people, with 25 still in hospital. In Punjab, a speeding car killed eight workers and injured 13. Cancer Care: India will cut prices of 137 cancer medicines by up to 70% from November 9, easing costs for patients. Food Safety: FSSAI has proposed banning added sucrose and fructose in nutrition products for babies up to six months, and issued notices to Nestlé India and Hindustan Unilever over product claims and compliance. Hospital Services: Delhi’s Lok Nayak Hospital has added a CT scanner and three MRI machines to expand diagnostic capacity. Prescription Ethics: The Supreme Court has asked the Centre to form an expert committee on drug-company ties with doctors, amid calls for stronger rules against paid prescriptions.

Festival Emergencies: A Kolkata Durga Puja stampede killed 19 people and injured 25; authorities are investigating crowd-control failures. In Madhya Pradesh, a truck crash near a Gwalior temple killed at least 14, with families alleging police delays in rescue and hospital transfers. Cancer Care: India will cap trade margins on 137 cancer medicines at 30%, with prices expected to fall by up to 70% from November 9. Infant Nutrition: FSSAI has proposed barring added sucrose and fructose in foods for babies up to six months; the draft is open for public comment for 60 days. Healthcare Access: Tata Trusts plans 40–50 not-for-profit hospitals and says its health strategy will strengthen more than 100 public facilities across 35 priority districts.

Kolkata Stampede: At least 19 people were killed and 25 injured at a Durga Puja gathering; heavy rain and crowd-control failures are under investigation, and police have detained organisers and security staff. Cancer Care: The government has capped trade margins at 30% on 137 cancer drug formulations, with prices expected to fall by up to 70% from November 9. Food Safety: FSSAI has proposed restricting added sugars in foods for babies under six months. Separately, food safety inspections found expired products and hygiene lapses at Delhi facilities, while Maharashtra suspended licences at five warehouses over allegedly mishandled food stock. Hospital Access: Tata Trusts plans to build a network of 40–50 not-for-profit hospitals, with paying patients helping fund care for people who cannot afford it.

Infant Nutrition: FSSAI has proposed banning added sucrose and fructose in nutrition products for babies up to six months old. The draft is open for public comment for 60 days. Patient Safety: Rajasthan police arrested two people accused of using forged medical qualifications to obtain registration; one allegedly ran a 100-bed hospital and performed surgeries. Healthcare Access: Tata Trusts plans 40–50 not-for-profit hospitals, with paying patients helping subsidise care for people unable to afford treatment. Its five-year strategy also targets stronger public facilities and expanded care for older people. Safety Lapses: A blast at a pharmaceutical factory in Gujarat killed five workers and injured five; officials reported a gas leak. Mumbai’s FDA also suspended the licence of a Fortis Hospital kitchen after cockroaches were found. Industry: AstraZeneca opened a Mumbai office as it expands its India presence; the company says it is running about 80 global clinical trials in the country. Hospital Update: L.K. Advani, 98, was admitted to Delhi’s Apollo Hospital with a chest infection and is reported to be stable.

Food Safety: Maharashtra suspended 29 food licences after inspections found serious lapses, including cockroaches and contaminated equipment in a Fortis Hospital kitchen serving patients. FSSAI also flagged hygiene and food-storage problems at Delhi’s Radisson Blu. Drug Safety: Punjab seized medicines worth ₹20.64 crore and suspended 520 chemist licences in a crackdown on violations. Care Capacity: India may need 2.9 million more hospital beds by 2035; the Allahabad High Court has also asked Uttar Pradesh to plan better neonatal and paediatric care across government medical colleges. Student Well-being: A Hingoli student’s death after the NEET-UG cancellation has renewed concern about the lack of mental-health support for exam-distressed students; experts caution that suicide has multiple causes. Health Systems: NITI Aayog is considering policy steps to strengthen domestic medical and dental device manufacturing, while a new report warns that hurdles are slowing expansion of primary-care centres in slum areas.

Hospital Pricing: Maharashtra has ordered private hospitals to display updated service rates in Marathi and English, aiming to make costs clearer and curb surprise bills. Food Safety: FSSAI issued a notice to the operator of Delhi’s Radisson Blu after finding pest activity, poor refrigeration, deteriorated produce and other hygiene lapses. Cancer Care: Mankind Pharma will buy a 70% stake in Belgian biotech Armed Cell Therapeutics for €48 million, entering CAR-T development for lymphoma and small-cell lung cancer. Air Pollution: A large international study linked every 10 μg/m³ rise in PM2.5 to an 8% increase in overall hospitalisation risk over the following 21 days, with effects extending beyond respiratory illness. Medical Devices: ICMR selected seven centres at IITs, IISc and Amrita to develop affordable devices and diagnostics, offering up to ₹15 crore per centre over five years. Drug Safety: Punjab reported seizing ₹20.64 crore worth of medicines and suspending 520 chemist licences during an 18-month enforcement drive; new controls on pregabalin take effect November 12.

Food Safety: Maharashtra has banned loose spice sales after tests found carcinogenic dyes, including Sudan dye and lead chromate; manufacturers face inspections and possible prosecution. Drug Enforcement: Punjab says it seized medicines worth ₹20.64 crore and suspended 520 chemists’ licences during a crackdown on violations. Infectious Disease: Mumbai doctors report more severe malaria cases, including critical illness linked to vivax malaria, and warn patients against delaying care or self-medicating. Hospital Access: Delhi’s LNJP Hospital has added MRI and CT scanners expected to double scanning capacity, easing waits that reached up to two to three years. Mental Health: A new report highlights long delays in care: more than half of patients waited at least a year for professional support, while 56% reported thoughts of self-harm before seeking help. Drug Innovation: The government is offering startups up to ₹50 crore for drug discovery, but experts say India also needs stronger clinical-trial infrastructure. Medicine Affordability: Novo Nordisk has cut the price of its growth hormone therapy Norditropin FlexPro by up to 35%.

Mental Health: A new report highlights long waits for care: more than half of people surveyed lived with mental health conditions for a year before seeking help, and 56% reported thoughts of self-harm. Public Hospitals: Delhi’s Lok Nayak Hospital has added a CT scanner and three MRI machines to improve diagnosis; Mumbai’s civic body has approved 180 days of paid maternity leave for outsourced health workers, with implementation under way. Patient Safety: Maharashtra’s FDA suspended three Mumbai blood banks after they offered donors gifts, including Titan watches. Clinical Research: NIPER Raebareli and AstraZeneca are partnering to upgrade 25 clinical trial sites, aiming to strengthen research capacity in India.

Clinical Research: NIPER Raebareli and AstraZeneca will strengthen 25 clinical-trial sites beyond major cities, with training and support to help more regions take part in global research. Rural Healthcare: Jammu and Kashmir LG Manoj Sinha urged doctors to ensure new medicines and diagnostic tools reach village patients, not just urban hospitals. Mental Health: An Amaha report found that more than half of respondents waited over a year to seek professional help; 56.2% reported thoughts of self-harm before getting care. Patient Safety: Maharashtra suspended three Mumbai blood-bank licences after donors were offered watches, which national guidelines prohibit. Cancer Care: Biocon settled patent disputes over its breast-cancer biosimilar Pebrilzo, clearing the way for planned launches in several markets, subject to regulatory approval.

Clinical Research: NIPER Raebareli and AstraZeneca India plan to train staff and prepare trial sites in 25 emerging regions, supporting a national goal of 1,000 advanced clinical-trial sites. Breast Cancer: Screening remains a major gap: just 0.9% of women aged 30–49 reported ever having a breast examination in the 2019–21 family health survey, while many Indian patients are diagnosed after cancer has spread. Nursing & Prevention: A tele-mentoring programme delivered 49 sessions across seven hubs, reaching 447 nurses with cervical-cancer prevention training. Patient Safety: The National Medical Commission cited an estimate of 52 lakh patient injuries a year from medical errors and urged hospitals to strengthen safety measures; the Centre has also asked states to ensure hospitals display treatment rates. Healthcare Access: Palghar still lacks fully operational key public facilities, leaving many rural and tribal patients reliant on hospitals outside the district. Climate & Health: Heat, floods and changing rainfall can shift disease patterns and outbreak risks, while gaps in surveillance may limit India’s ability to respond.